ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
Accustem Sciences Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.15+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $2.37M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.1525 (−88.65%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $2.37M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$1.65M
- EPS, diluted
- -$0.10
- Book value per share
- -$0.26
- Diluted shares
- 16M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Operating income
-$1.65M
Net income
-$1.65M
EPS, diluted
-$0.10
Free cash flow
–
Reported periodTrailing twelve months